What is reverse T3 (rT3)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 26, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

What is Reverse T3 (rT3)?

Reverse T3 (rT3) is a biologically inactive isomer of triiodothyronine (T3) produced when thyroxine (T4) undergoes peripheral deiodination by type 1 and type 3 deiodinase enzymes (D1 and D3). Unlike active T3, which binds to nuclear thyroid hormone receptors to regulate gene transcription, rT3 binds weakly to these receptors and is generally considered an inactive metabolic byproduct 1.

Biochemical Formation and Metabolism

rT3 is created through inner ring deiodination of T4, representing an alternative metabolic pathway that diverts T4 away from active T3 production 1. Approximately 40% of T4 is converted to rT3 under normal physiological conditions. This metabolic shunt becomes particularly prominent during physiological stress, severe illness, chronic inflammation, or trauma, when increased D3 activity shifts T4 metabolism preferentially toward rT3 rather than active T3 2.

Clinical Significance and Controversy

Traditional View

The established endocrinology guidelines do not recommend routine rT3 testing, as it has limited clinical utility in standard thyroid function assessment 3, 4. Professional practice guidelines from the American Thyroid Association and American Association of Clinical Endocrinologists do not include rT3 measurement in their diagnostic algorithms for thyroid dysfunction 5.

Nonthyroidal Illness Syndrome

rT3 levels become elevated in critically ill patients as part of "euthyroid sick syndrome" or nonthyroidal illness syndrome 6, 1. During severe illness, the body increases rT3 production while decreasing active T3, likely as an adaptive mechanism to reduce metabolic rate. However, even in this context, rT3 measurement adds little diagnostic value beyond standard thyroid function tests 5.

Emerging Research Perspectives

Recent studies suggest rT3 may not be entirely inactive:

  • Competitive inhibition: rT3 may competitively block T3 binding at receptor sites, potentially reducing thyroid hormone bioavailability 6, 2
  • Functional hypothyroidism: Elevated rT3 with normal TSH and T4 may create a state where intracellular T3 action is diminished despite normal standard labs 2
  • Neuropsychiatric correlations: Higher rT3 levels and lower T3/rT3 ratios have been associated with depression, bipolar disorder, anxiety, and cognitive impairment 2
  • Cellular effects: Some research indicates rT3 may bind to extra-nuclear receptors and potentially affect cell proliferation 1, 7

Factors Affecting rT3 Levels

Medications: Amiodarone and high-dose propranolol inhibit T4 to T3 conversion, increasing rT3 3, 1

Thyroid replacement therapy: Patients on levothyroxine (L-T4) alone show the highest rates of elevated rT3 (20.9%), while those on preparations containing L-T3 have the lowest rT3 levels 6

Physiological stress: Trauma, severe illness, and chronic inflammation increase D3 activity, elevating rT3 2

Critical Clinical Caveat

Despite growing interest in functional medicine circles, routine rT3 testing is not recommended by any major endocrinology professional organization 5. A review of rT3 orders found that 55% (11 of 20) appeared clinically inappropriate, and these inappropriate orders were less likely to have been placed at an endocrinologist's recommendation 5. Physiologic doses of rT3 administered to normal volunteers produced no changes in TSH, T3, T4, or prolactin levels, suggesting that elevated rT3 alone does not directly impair thyroid-pituitary function 8.

When rT3 Measurement May Be Considered

While not part of standard guidelines, rT3 analysis can provide diagnostic information for:

  • Genetic conditions affecting iodothyronine deiodinases
  • Thyroid transporter or transport protein abnormalities
  • Distinguishing patterns in complex cases where standard thyroid tests are discordant 1

The key takeaway: rT3 is a metabolic byproduct of T4 that lacks significant thyroid hormone activity at physiologic concentrations, and its routine measurement is not supported by evidence-based guidelines for standard thyroid disease diagnosis or management.

References

Guideline

hyperthyroidism and other causes of thyrotoxicosis: management guidelines of the american thyroid association and american association of clinical endocrinologists.

Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologist, 2011

Guideline

clinical practice guidelines for hypothyroidism in adults: cosponsored by the american association of clinical endocrinologists and the american thyroid association.

Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologist, 2012

Research

Action of Reverse T3 on Cancer Cells.

Endocrine research, 2019

Research

The failure of physiologic doses of reverse T3 to effect thyroid-pituitary function in man.

The Journal of clinical endocrinology and metabolism, 1976

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.